Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index; 14 of the 24 sources its claims cite were checked for support.

Exercise‐induced α‐ketoglutaric acid stimulates muscle hypertrophy and fat loss through OXGR1‐dependent adrenal activation

Open access

Published version of a preprint

Abstract

Beneficial effects of resistance exercise on metabolic health and particularly muscle hypertrophy and fat loss are well established, but the underlying chemical and physiological mechanisms are not fully understood. Here, we identified a myometabolite‐mediated metabolic pathway that is essential for the beneficial metabolic effects of resistance exercise in mice. We showed that substantial accumulation of the tricarboxylic acid cycle intermediate α‐ketoglutaric acid (AKG) is a metabolic signature of resistance exercise performance. Interestingly, human plasma AKG level is also negatively correlated with BMI. Pharmacological elevation of circulating AKG induces muscle hypertrophy, brown adipose tissue (BAT) thermogenesis, and white adipose tissue (WAT) lipolysis in vivo . We further found that AKG stimulates the adrenal release of adrenaline through 2‐oxoglutarate receptor 1 (OXGR1) expressed in adrenal glands. Finally, by using both loss‐of‐function and gain‐of‐function mouse models, we showed that OXGR1 is essential for AKG‐mediated exercise‐induced beneficial metabolic effects. These findings reveal an unappreciated mechanism for the salutary effects of resistance exercise, using AKG as a systemically derived molecule for adrenal stimulation of muscle hypertrophy and fat loss.

Overview

CoChat Summary

TL;DR

This study reports that resistance exercise raises circulating α-ketoglutaric acid (AKG), and that AKG can mimic several exercise benefits in mice, including increased lean mass and reduced fat mass. The authors propose that AKG acts through adrenal OXGR1 to stimulate epinephrine release, driving adipose thermogenesis and lipolysis.

Key findings

  • Acute resistance exercise in mice changed 56 metabolites significantly at peak exercise, and AKG was one of the metabolites that increased; after exercise, serum AKG rose to 105.41 ± 4.78 μM in chow-fed mice and 94.93 ± 3.8 μM in HFD-fed mice, versus 64.11 ± 3.23 μM and 50.13 ± 3.3 μM in non-exercise controls.
  • In humans, plasma AKG was negatively correlated with several adiposity measures, including BMI (R = −0.58, P < 0.001), hip circumference (R = −0.48, P < 0.01), waist circumference (R = −0.46, P < 0.01), fat mass (R = −0.42, P < 0.01), and body weight (R = −0.4, P < 0.001).
  • In mice, 2% AKG in drinking water increased lean mass and muscle size, but on chow it also increased body weight and food intake; in HFD-fed mice it reduced body weight gain and fat mass while increasing energy expenditure, BAT thermogenesis, and WAT lipolysis.
  • Mechanistically, AKG increased adrenal epinephrine release, and the effects on energy expenditure/fat loss were blocked by adrenalectomy, ADRB3 inhibition (SR59230A), or OXGR1 knockout; adrenal-specific OXGR1 reexpression or overexpression restored or enhanced AKG’s anti-obesity effects.

Methods

  • Comparative metabolomics in mice after acute resistance exercise (ladder climbing), with additional comparisons to endurance and wheel-running exercise; serum and muscle metabolites were measured by LC–MS/MS / GC–TOFMS-based metabolomics.
  • Mouse intervention studies used male and female C57BL/6 mice, chow or high-fat diet (HFD), 2% AKG in water, and multiple loss-/gain-of-function models including global OXGR1 knockout, adrenal-specific OXGR1 reexpression, adrenal-specific OXGR1 overexpression, and adrenalectomy.
  • Mechanistic analyses included adrenal chromaffin cell culture and ex vivo adrenal gland assays, transcriptomics/RNA-seq, NF-κB pathway testing, oxygen consumption and thermogenesis measurements, and a small human observational study of 45 Chinese volunteers with plasma AKG measured by LC–MS/MS and BMI recorded.

Limitations

  • The paper itself notes that adrenal reexpression of OXGR1 cannot fully rescue the anti-obesity effects of AKG, so “other OXGR1 pathways may be involved.”
  • The authors say they cannot exclude roles of OXGR1 in other tissues, including possible central nervous system effects.
  • Evident from the text: the human data are observational and small (n = 45), so they support correlation with BMI but not causation.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.15252/embj.2019103304

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 AKG synthesis is induced by exercises A–CMouse body weight gain (A), lean mass and fat mass (B), and gWAT index (C). At 8 weeks of age, male C57BL/6 mice were switched to HFD. After 12 weeks of HFD feeding, mice were divided into three groups receiving non‐exercise, endurance exercise, or resistance exercise for 14 days (n = 8 per group).DRelative changes in metabolites in response to resistance exercise. Heat maps show changes in metabolites in the serums from mice receiving resistance exercise or non‐exercise. Male C57BL/6 mice (10 weeks old) fed with normal chow were divided into two groups receiving either non‐exercise or resistance exercise for 40 min (n = 6 per group). Shades of yellow and blue represent fold increase and fold decrease in a metabolite, respectively (see color scale).EA volcano plot of metabolome. Metabolites with log2FC ≥ 0.58 and −log10 P value ≥ 1.3 were considered significant. Fatty acid (red dots) and amino acid (blue dots) metabolites were found to be significantly different between groups (n = 6 per group).FEnrichment of tricarboxylic acid cycle (TCA cycle) intermediates/AKG metabolites in serum during resistance exercise. Blue color indicates significant decreases, while red color indicates significant increases by the volcano plot analysis between groups in serum metabolite levels (Val: valine; Leu: leucine; Ala: alanine; Met: methionine; Tyr: tyrosine; Orn: ornithine; Asp: aspartic acid; Glu: glutamic acid; Pro: proline; SUA: succinic acid; FUMA: fumaric acid; OAA: oxaloacetic acid; AKG: oxoglutaric acid; α‐keval: alpha‐ketoisovaleric acid; 2H3MA: 2‐hydroxy‐3‐methylbutyric acid; α‐kehex: α‐ketoleucine; Pyr: pyruvic acid).GTwo‐tailed Pearson's correlation coefficient analysis of plasma AKG level and body mass index (BMI) in Chinese adults (10 males and 35 females).HSerum AKG concentration–time profile obtained before and after 40‐min resistance exercise. At 8 weeks of age, male C57BL/6 mice were switched to HFD and continuously fed with HFD for 12 weeks. At 20 weeks of age, mice received resistance exercise for 40 min. Another group of chow‐fed male C57BL/6 mice (10 weeks old) received resistance exercise for 40 min. The serum AKG level was tested at 0, 1, 2, 4, and 6 h after exercise (n = 8–10 per group).ISerum AKG levels after exercise. Male C57BL/6 mice (10 weeks old) fed with normal chow were divided into three groups receiving non‐exercise, free access to running wheel for 1 day, or resistance exercise for 40 min (n = 8–10 per group).JMuscle AKG levels after exercise. Male C57BL/6 mice (10 weeks old) fed with normal chow were divided into two groups receiving either non‐exercise or resistance exercise for 40 min (n = 6 per group).K–MMuscle ICDHm (K), GDH (L), and α‐KGDH (M) enzyme activity after exercise. Male C57BL/6 mice (10 weeks old) fed with normal chow were divided into three groups receiving non‐exercise, free access to running wheel for 1 day, or resistance exercise for 40 min (n = 8–9 per group).Data information: Results are presented as mean ± SEM. In (A), *P ≤ 0.05 (Control versus Endurance exercise) and # P ≤ 0.05 (Control versus Resistance exercise) by two‐way ANOVA followed by post hoc Bonferroni tests. In (B–C and I–M), *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001 by one‐way ANOVA followed by post hoc Tukey's tests. In (H), *P ≤ 0.05 (Chow) and # P ≤ 0.05 (HFD) by non‐paired Student's t‐test compared with before exercise.
Figure 1 AKG synthesis is induced by exercises A–CMouse body weight gain (A), lean mass and fat mass (B), and gWAT index (C). At 8 weeks of age, male C57BL/6 mice were switched to HFD. After 12 weeks of HFD feeding, mice were divided into three groups receiving non‐exercise, endurance exercise, or resistance exercise for 14 days (n = 8 per group).DRelative changes in metabolites in response to resistance exercise. Heat maps show changes in metabolites in the serums from mice receiving resistance exercise or non‐exercise. Male C57BL/6 mice (10 weeks old) fed with normal chow were divided into two groups receiving either non‐exercise or resistance exercise for 40 min (n = 6 per group). Shades of yellow and blue represent fold increase and fold decrease in a metabolite, respectively (see color scale).EA volcano plot of metabolome. Metabolites with log2FC ≥ 0.58 and −log10 P value ≥ 1.3 were considered significant. Fatty acid (red dots) and amino acid (blue dots) metabolites were found to be significantly different between groups (n = 6 per group).FEnrichment of tricarboxylic acid cycle (TCA cycle) intermediates/AKG metabolites in serum during resistance exercise. Blue color indicates significant decreases, while red color indicates significant increases by the volcano plot analysis between groups in serum metabolite levels (Val: valine; Leu: leucine; Ala: alanine; Met: methionine; Tyr: tyrosine; Orn: ornithine; Asp: aspartic acid; Glu: glutamic acid; Pro: proline; SUA: succinic acid; FUMA: fumaric acid; OAA: oxaloacetic acid; AKG: oxoglutaric acid; α‐keval: alpha‐ketoisovaleric acid; 2H3MA: 2‐hydroxy‐3‐methylbutyric acid; α‐kehex: α‐ketoleucine; Pyr: pyruvic acid).GTwo‐tailed Pearson's correlation coefficient analysis of plasma AKG level and body mass index (BMI) in Chinese adults (10 males and 35 females).HSerum AKG concentration–time profile obtained before and after 40‐min resistance exercise. At 8 weeks of age, male C57BL/6 mice were switched to HFD and continuously fed with HFD for 12 weeks. At 20 weeks of age, mice received resistance exercise for 40 min. Another group of chow‐fed male C57BL/6 mice (10 weeks old) received resistance exercise for 40 min. The serum AKG level was tested at 0, 1, 2, 4, and 6 h after exercise (n = 8–10 per group).ISerum AKG levels after exercise. Male C57BL/6 mice (10 weeks old) fed with normal chow were divided into three groups receiving non‐exercise, free access to running wheel for 1 day, or resistance exercise for 40 min (n = 8–10 per group).JMuscle AKG levels after exercise. Male C57BL/6 mice (10 weeks old) fed with normal chow were divided into two groups receiving either non‐exercise or resistance exercise for 40 min (n = 6 per group).K–MMuscle ICDHm (K), GDH (L), and α‐KGDH (M) enzyme activity after exercise. Male C57BL/6 mice (10 weeks old) fed with normal chow were divided into three groups receiving non‐exercise, free access to running wheel for 1 day, or resistance exercise for 40 min (n = 8–9 per group).Data information: Results are presented as mean ± SEM. In (A), *P ≤ 0.05 (Control versus Endurance exercise) and # P ≤ 0.05 (Control versus Resistance exercise) by two‐way ANOVA followed by post hoc Bonferroni tests. In (B–C and I–M), *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001 by one‐way ANOVA followed by post hoc Tukey's tests. In (H), *P ≤ 0.05 (Chow) and # P ≤ 0.05 (HFD) by non‐paired Student's t‐test compared with before exercise.CC BY · PubMed Central
Figure EV1 Physiological relevance of AKG A–DThe serum concentration of succinic acid (A), malic acid (B), hypoxanthine (C), and xanthine (D) in mice. Chow‐fed male C57BL/6 mice (10 weeks old) were divided into three groups receiving non‐exercise, endurance exercise (treadmill, 10 m/min, increased by 2 m/min every 2 min to exhaustion), or resistance exercise (ladder‐climbing for 40 min) (n = 8 per group).ETwo‐tailed Pearson's correlation coefficient analysis of plasma AKG level and the running distance of wheels. Chow‐fed male C57BL/6 mice (10 weeks old) received 1‐day free access to running wheel (n = 10 per group).FSerum AKG level after electrical stimulation. Electrical stimulation was performed in unilateral gastrocnemius for 40 min (1 ms width/50 Hz, 10 times, each time for 4 min, resting for 2 min between stimulations) in vivo in 10‐week‐old male C57BL/6 mice fed with chow diet (n = 8‐9 per group).GSerum lactate concentration. Chow‐fed male C57BL/6 mice (10 weeks old) received resistance exercise for 40 min. The serum lactate concentration was tested before and immediately after exercise (n = 10 per group).HTwo‐tailed Pearson's correlation coefficient analysis of human plasma AKG level and body mass index (BMI), hip circumference (HCF), waist circumference (WCF), fat mass, body weight, visceral fat (VF), neck circumference (NCF), systolic pressure, diastolic pressure, height, and age. **P ≤ 0.01 and ***P ≤ 0.001 indicate significant correlation between human plasma AKG level and BMI, HCF, WCF, fat mass, and body weight by one‐way ANOVA followed by post hoc Tukey's tests. Red: negative correlation; blue: positive correlation.Data information: Results are presented as mean ± SEM. In (A–D and G), *P ≤ 0.05 by one‐way ANOVA followed by post hoc Tukey's tests.
Figure EV1 Physiological relevance of AKG A–DThe serum concentration of succinic acid (A), malic acid (B), hypoxanthine (C), and xanthine (D) in mice. Chow‐fed male C57BL/6 mice (10 weeks old) were divided into three groups receiving non‐exercise, endurance exercise (treadmill, 10 m/min, increased by 2 m/min every 2 min to exhaustion), or resistance exercise (ladder‐climbing for 40 min) (n = 8 per group).ETwo‐tailed Pearson's correlation coefficient analysis of plasma AKG level and the running distance of wheels. Chow‐fed male C57BL/6 mice (10 weeks old) received 1‐day free access to running wheel (n = 10 per group).FSerum AKG level after electrical stimulation. Electrical stimulation was performed in unilateral gastrocnemius for 40 min (1 ms width/50 Hz, 10 times, each time for 4 min, resting for 2 min between stimulations) in vivo in 10‐week‐old male C57BL/6 mice fed with chow diet (n = 8‐9 per group).GSerum lactate concentration. Chow‐fed male C57BL/6 mice (10 weeks old) received resistance exercise for 40 min. The serum lactate concentration was tested before and immediately after exercise (n = 10 per group).HTwo‐tailed Pearson's correlation coefficient analysis of human plasma AKG level and body mass index (BMI), hip circumference (HCF), waist circumference (WCF), fat mass, body weight, visceral fat (VF), neck circumference (NCF), systolic pressure, diastolic pressure, height, and age. **P ≤ 0.01 and ***P ≤ 0.001 indicate significant correlation between human plasma AKG level and BMI, HCF, WCF, fat mass, and body weight by one‐way ANOVA followed by post hoc Tukey's tests. Red: negative correlation; blue: positive correlation.Data information: Results are presented as mean ± SEM. In (A–D and G), *P ≤ 0.05 by one‐way ANOVA followed by post hoc Tukey's tests.CC BY · PubMed Central
Figure 2 AKG prevents diet‐induced obesity ASerum AKG concentration–time profile obtained from male C57BL/6 mice (10 weeks old) fed with normal chow before or after AKG gavage (10 mg/kg). The serum AKG level was tested at 0, 1, 2, 4, and 6 h after gavage (n = 8 per group).B–DWater intake (B), cumulative food intake (C), and body weight gain (D) of male C57BL/6 mice. At 12 weeks of age, mice were switched to HFD and received tap water or water supplemented with 2% AKG for 11 weeks (n = 9 per group).E, FFat and lean mass (E) and representative images (F) of body composition from male mice after 11 weeks of AKG supplementation (n = 9 per group).G–IWeight index of BAT (G), gWAT (H), and iWAT (I) from male mice after 11 weeks of AKG supplementation (n = 9 per group).JSerum AKG level of male mice after 11 weeks of AKG supplementation (n = 9 per group).K, LRepresentative images (K) and quantification (L) of gWAT and iWAT HE staining from male mice after 11 weeks of AKG supplementation (n = 9 per group).M–OWater intake (M), cumulative food intake (N), and body weight gain (O) of female C57BL/6 mice. At 12 weeks of age, mice were switched to HFD and received tap water or water supplemented with 2% AKG for 11 weeks (n = 9 per group).P, QFat and lean mass index (P) and representative image (Q) of body composition from female mice after 11 weeks of AKG supplementation (n = 9 per group).R–TWeight index of BAT (R), gWAT (S), and iWAT (T) from female mice after 11 weeks of AKG supplementation (n = 9 per group).U, VRepresentative images (U) and quantification (V) of gWAT and iWAT HE staining from female mice after 11 weeks of AKG supplementation (n = 9 per group).Data information: Results are presented as mean ± SEM. In (A), *P ≤ 0.05 by non‐paired Student's t‐test compared with before gavage. In (B–D and M–O), *P ≤ 0.05 by two‐way ANOVA followed by post hoc Bonferroni tests. In (E, G–J, L, P, R–T and V), *P ≤ 0.05 and **P ≤ 0.01 by non‐paired Student's t‐test.
Figure 2 AKG prevents diet‐induced obesity ASerum AKG concentration–time profile obtained from male C57BL/6 mice (10 weeks old) fed with normal chow before or after AKG gavage (10 mg/kg). The serum AKG level was tested at 0, 1, 2, 4, and 6 h after gavage (n = 8 per group).B–DWater intake (B), cumulative food intake (C), and body weight gain (D) of male C57BL/6 mice. At 12 weeks of age, mice were switched to HFD and received tap water or water supplemented with 2% AKG for 11 weeks (n = 9 per group).E, FFat and lean mass (E) and representative images (F) of body composition from male mice after 11 weeks of AKG supplementation (n = 9 per group).G–IWeight index of BAT (G), gWAT (H), and iWAT (I) from male mice after 11 weeks of AKG supplementation (n = 9 per group).JSerum AKG level of male mice after 11 weeks of AKG supplementation (n = 9 per group).K, LRepresentative images (K) and quantification (L) of gWAT and iWAT HE staining from male mice after 11 weeks of AKG supplementation (n = 9 per group).M–OWater intake (M), cumulative food intake (N), and body weight gain (O) of female C57BL/6 mice. At 12 weeks of age, mice were switched to HFD and received tap water or water supplemented with 2% AKG for 11 weeks (n = 9 per group).P, QFat and lean mass index (P) and representative image (Q) of body composition from female mice after 11 weeks of AKG supplementation (n = 9 per group).R–TWeight index of BAT (R), gWAT (S), and iWAT (T) from female mice after 11 weeks of AKG supplementation (n = 9 per group).U, VRepresentative images (U) and quantification (V) of gWAT and iWAT HE staining from female mice after 11 weeks of AKG supplementation (n = 9 per group).Data information: Results are presented as mean ± SEM. In (A), *P ≤ 0.05 by non‐paired Student's t‐test compared with before gavage. In (B–D and M–O), *P ≤ 0.05 by two‐way ANOVA followed by post hoc Bonferroni tests. In (E, G–J, L, P, R–T and V), *P ≤ 0.05 and **P ≤ 0.01 by non‐paired Student's t‐test.CC BY · PubMed Central
Figure EV2 Metabolic effects of AKG in mice fed on chow A, BBody weight gain (A) and cumulative food intake (B) of male C57BL/6 mice. At 12 weeks of age, chow‐fed male mice were divided into two groups receiving tap water or water supplemented with 2% AKG for 6 weeks (n = 8 per group).C, DBody composition (C) and tissue weight (D) of male mice treated with AKG for 6 weeks (n = 7–8 per group).E, FRepresentative images (E) and quantification (F) of gWAT HE staining from male mice treated with AKG for 6 weeks (n = 8 per group).G, HBody weight gain (G) and cumulative food intake (H) of female C57BL/6 mice. At 12 weeks of age, chow‐fed female mice were divided into two groups receiving tap water or water supplemented with 2% AKG for 11 weeks (n = 8 per group).I, JBody composition (I) and tissue weight (J) of female mice treated with AKG for 11 weeks (n = 8 per group).K, LRepresentative images (K) and quantification (L) of gWAT HE staining from female mice treated with AKG for 11 weeks (n = 8 per group).MThe mRNA expression of thermogenic genes in BAT of male C57BL/6 mice supplemented with AKG for 6 weeks (n = 6 per group).N–PImmunoblots and quantification of UCP1 (N) and representative images of DAB staining (O) and quantification (P) of UCP1 in BAT of male mice supplemented with AKG for 6 weeks (n = 3–6 per group).Q–USerum levels of NEFA (Q), E (R), NE (S), T3 (T), and T4 (U) in male mice supplemented with AKG for 6 weeks (n = 6 per group).Data information: Results are presented as mean ± SEM. In (A, B, G and H), *P ≤ 0.05 by two‐way ANOVA followed by post hoc Bonferroni tests. In (C, D, F, I, J, L–N and P–U), *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.01 by non‐paired Student's t‐test.Source data are available online for this figure.
Figure EV2 Metabolic effects of AKG in mice fed on chow A, BBody weight gain (A) and cumulative food intake (B) of male C57BL/6 mice. At 12 weeks of age, chow‐fed male mice were divided into two groups receiving tap water or water supplemented with 2% AKG for 6 weeks (n = 8 per group).C, DBody composition (C) and tissue weight (D) of male mice treated with AKG for 6 weeks (n = 7–8 per group).E, FRepresentative images (E) and quantification (F) of gWAT HE staining from male mice treated with AKG for 6 weeks (n = 8 per group).G, HBody weight gain (G) and cumulative food intake (H) of female C57BL/6 mice. At 12 weeks of age, chow‐fed female mice were divided into two groups receiving tap water or water supplemented with 2% AKG for 11 weeks (n = 8 per group).I, JBody composition (I) and tissue weight (J) of female mice treated with AKG for 11 weeks (n = 8 per group).K, LRepresentative images (K) and quantification (L) of gWAT HE staining from female mice treated with AKG for 11 weeks (n = 8 per group).MThe mRNA expression of thermogenic genes in BAT of male C57BL/6 mice supplemented with AKG for 6 weeks (n = 6 per group).N–PImmunoblots and quantification of UCP1 (N) and representative images of DAB staining (O) and quantification (P) of UCP1 in BAT of male mice supplemented with AKG for 6 weeks (n = 3–6 per group).Q–USerum levels of NEFA (Q), E (R), NE (S), T3 (T), and T4 (U) in male mice supplemented with AKG for 6 weeks (n = 6 per group).Data information: Results are presented as mean ± SEM. In (A, B, G and H), *P ≤ 0.05 by two‐way ANOVA followed by post hoc Bonferroni tests. In (C, D, F, I, J, L–N and P–U), *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.01 by non‐paired Student's t‐test.Source data are available online for this figure.CC BY · PubMed Central
Figure 3 AKG increases fat thermogenesis and lipolysis A, BOxygen consumption in male C57BL/6 mice after 11 weeks of AKG supplementation (n = 8 per group).CBody temperature of male mice after 11 weeks of AKG supplementation (n = 9 per group).D, ERepresentative images (D) and quantification (E) of BAT thermogenesis induced by 6‐h cold exposure at 4°C in male mice supplemented with AKG for 11 weeks (n = 9 per group).F, GThe mRNA expression of thermogenic genes (F) and immunoblots and quantification (G) of UCP1 protein in BAT of male mice after 11 weeks of AKG supplementation (n = 3–6 per group).H, IDAB staining (H) and quantification (I) of UCP1 in BAT of male mice supplemented with AKG for 11 weeks (n = 9 per group).JSerum levels of NEFA in male mice supplemented with AKG for 11 weeks (n = 9 per group).KThe mRNA expression of CD137, CD40, TBX1, TMEM26, CITED1, and slc27a1 in iWAT of male mice supplemented with AKG for 11 weeks (n = 8 per group).L, MRespiratory exchange ratio (RER) in male C57BL/6 mice after 11 weeks of AKG supplementation (n = 8 per group).N, OImmunoblots (N) and quantification (O) of p‐HSL and ATGL protein in gWAT of male mice after 11 weeks of AKG supplementation (n = 3 per group).P, QRepresentative images (P) and quantification (Q) of p‐HSL DAB staining in gWAT and iWAT of male mice after 11 weeks of AKG supplementation (n = 9 per group).RThe mRNA expression of PPARγ, FASN, and ACC in the gWAT and iWAT from male mice supplemented with AKG for 11 weeks (n = 6 per group).S–VSerum levels of E (S), NE (T), T3 (U), and T4 (V) in male mice supplemented with AKG for 11 weeks (n = 8–9 per group).Data information: Results are presented as mean ± SEM. In (B, C, E–G, I–K, M, O and Q–V), *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001 by non‐paired Student's t‐test.
Figure 3 AKG increases fat thermogenesis and lipolysis A, BOxygen consumption in male C57BL/6 mice after 11 weeks of AKG supplementation (n = 8 per group).CBody temperature of male mice after 11 weeks of AKG supplementation (n = 9 per group).D, ERepresentative images (D) and quantification (E) of BAT thermogenesis induced by 6‐h cold exposure at 4°C in male mice supplemented with AKG for 11 weeks (n = 9 per group).F, GThe mRNA expression of thermogenic genes (F) and immunoblots and quantification (G) of UCP1 protein in BAT of male mice after 11 weeks of AKG supplementation (n = 3–6 per group).H, IDAB staining (H) and quantification (I) of UCP1 in BAT of male mice supplemented with AKG for 11 weeks (n = 9 per group).JSerum levels of NEFA in male mice supplemented with AKG for 11 weeks (n = 9 per group).KThe mRNA expression of CD137, CD40, TBX1, TMEM26, CITED1, and slc27a1 in iWAT of male mice supplemented with AKG for 11 weeks (n = 8 per group).L, MRespiratory exchange ratio (RER) in male C57BL/6 mice after 11 weeks of AKG supplementation (n = 8 per group).N, OImmunoblots (N) and quantification (O) of p‐HSL and ATGL protein in gWAT of male mice after 11 weeks of AKG supplementation (n = 3 per group).P, QRepresentative images (P) and quantification (Q) of p‐HSL DAB staining in gWAT and iWAT of male mice after 11 weeks of AKG supplementation (n = 9 per group).RThe mRNA expression of PPARγ, FASN, and ACC in the gWAT and iWAT from male mice supplemented with AKG for 11 weeks (n = 6 per group).S–VSerum levels of E (S), NE (T), T3 (U), and T4 (V) in male mice supplemented with AKG for 11 weeks (n = 8–9 per group).Data information: Results are presented as mean ± SEM. In (B, C, E–G, I–K, M, O and Q–V), *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001 by non‐paired Student's t‐test.CC BY · PubMed Central
Figure EV3 Effects of AKG supplementation on fecal microbiota composition and iWAT browning in male mice AFecal energy of male C57BL/6 mice after 1, 4, and 11 weeks of AKG supplementation. At 12 weeks of age, male C57BL/6 mice were switched to HFD and received tap water or water supplemented with 2% AKG for 11 weeks (n = 9 per group).B, CThe fecal microbial composition in the phylum (B) and genus (C) in male C57BL/6 mice receiving 2% AKG water supplementation for 1 weeks (AKG1) or 4 weeks (AKG2) (n = 5 per group).DCommunity structure test by ANOSIM and ADONIS of beta diversity in the genus between groups.E, FImmunoblots (E) and quantification (F) of UCP1 protein in the iWAT of male C57BL/6 mice. At 10 weeks of age, male C57BL/6 mice were switched from chow to HFD and divided into four groups receiving tap water + room temperature (RT, 23°C), tap water + cold exposure (6°C), 2% AKG supplementation + 23°C, and 2% AKG supplementation + 6°C for one week (n = 8 per group).G–IRepresentative images (G) and quantification (H, I) of HE staining or UCP1 staining in iWAT of male C57BL/6 mice (n = 8 per group).Data information: Results are presented as mean ± SEM. In (A), data are analyzed by two‐way ANOVA followed by post hoc Bonferroni tests. In (F, H and I), different letters between bars indicate P ≤ 0.05 by one‐way ANOVA followed by post hoc Tukey's tests.
Figure EV3 Effects of AKG supplementation on fecal microbiota composition and iWAT browning in male mice AFecal energy of male C57BL/6 mice after 1, 4, and 11 weeks of AKG supplementation. At 12 weeks of age, male C57BL/6 mice were switched to HFD and received tap water or water supplemented with 2% AKG for 11 weeks (n = 9 per group).B, CThe fecal microbial composition in the phylum (B) and genus (C) in male C57BL/6 mice receiving 2% AKG water supplementation for 1 weeks (AKG1) or 4 weeks (AKG2) (n = 5 per group).DCommunity structure test by ANOSIM and ADONIS of beta diversity in the genus between groups.E, FImmunoblots (E) and quantification (F) of UCP1 protein in the iWAT of male C57BL/6 mice. At 10 weeks of age, male C57BL/6 mice were switched from chow to HFD and divided into four groups receiving tap water + room temperature (RT, 23°C), tap water + cold exposure (6°C), 2% AKG supplementation + 23°C, and 2% AKG supplementation + 6°C for one week (n = 8 per group).G–IRepresentative images (G) and quantification (H, I) of HE staining or UCP1 staining in iWAT of male C57BL/6 mice (n = 8 per group).Data information: Results are presented as mean ± SEM. In (A), data are analyzed by two‐way ANOVA followed by post hoc Bonferroni tests. In (F, H and I), different letters between bars indicate P ≤ 0.05 by one‐way ANOVA followed by post hoc Tukey's tests.CC BY · PubMed Central
Figure 4 Metabolic effects of AKG are mediated by adrenergic stimulation of thermogenesis and lipolysis ASerum AKG concentration–time profile obtained from male C57BL/6 mice (10 weeks old) fed with normal chow before or after i.p AKG (10 mg/kg body weight). The serum AKG level was tested at 0, 1, 2, 4, and 6 h after injection (n = 8 per group).B, CRepresentative images (B) and quantification (C) of BAT thermogenesis after 6‐h cold exposure at 4°C. Male C57BL/6 mice (10 weeks old) were i.p. injected with 10 mg/kg AKG or saline and immediately exposed to cold stress at 4°C (n = 8 per group).DImmunoblots and quantification of p‐HSL and ATGL in the gWAT of male C57BL/6 mice (10 weeks old) 3 h after i.p. injection of 10 mg/kg AKG or saline (n = 3 per group).ESerum E level in AKG‐treated male mice 3 h after i.p. injection (n = 8 per group).F–IOxygen consumption (F‐G) and RER (H‐I) in male C57BL/6 mice (10 weeks old) i.p. injected with saline, 10 mg/kg AKG, 1 mg/kg SR59230A (ADRB3 inhibitor), or AKG + SR59230A (n = 8 per group). All injections were performed at 7:00 am of the second day. Data are summarized in bar graph (G and I) by light or dark cycle of the second day.J–NBody weight gain (J), cumulative food intake (K), body composition (L), fat weight (M), and serum NEFA (N) of sham or adrenalectomized male C57BL/6 mice. Male mice were adrenalectomized at 8 weeks of age. Two weeks after surgeries, male mice were switched to HFD and given free access to tap water or 2% AKG for 9 weeks (n = 8 per group).O, PRepresentative images (O) and quantification (P) of BAT thermogenesis after 6‐h cold exposure at 4°C in sham or adrenalectomized male mice treated with AKG for 9 weeks (n = 8 per group).QThe mRNA expression of thermogenic genes in the BAT of sham or adrenalectomized male mice treated with AKG for 9 weeks (n = 6 per group).R, SImmunoblots (R) and quantification (S) of p‐HSL and ATGL protein in the gWAT of sham or adrenalectomized male mice treated with AKG for 9 weeks (n = 4 per group).T, UImmunoblots (T) and quantification (U) of UCP1 protein in the BAT of sham or adrenalectomized male mice treated with AKG for 9 weeks (n = 4 per group).Data information: Results are presented as mean ± SEM. In (A), *P ≤ 0.05 by non‐paired Student's t‐test compared with before injection. In (C–E), *P ≤ 0.05 and **P ≤ 0.01 by non‐paired Student's t‐test. In (J, K), *P ≤ 0.05 by two‐way ANOVA followed by post hoc Bonferroni tests. In (G, I, L–N, P, Q, S and U), different letters between bars indicate P ≤ 0.05 by one‐way ANOVA followed by post hoc Tukey's tests.Source data are available online for this figure.
Figure 4 Metabolic effects of AKG are mediated by adrenergic stimulation of thermogenesis and lipolysis ASerum AKG concentration–time profile obtained from male C57BL/6 mice (10 weeks old) fed with normal chow before or after i.p AKG (10 mg/kg body weight). The serum AKG level was tested at 0, 1, 2, 4, and 6 h after injection (n = 8 per group).B, CRepresentative images (B) and quantification (C) of BAT thermogenesis after 6‐h cold exposure at 4°C. Male C57BL/6 mice (10 weeks old) were i.p. injected with 10 mg/kg AKG or saline and immediately exposed to cold stress at 4°C (n = 8 per group).DImmunoblots and quantification of p‐HSL and ATGL in the gWAT of male C57BL/6 mice (10 weeks old) 3 h after i.p. injection of 10 mg/kg AKG or saline (n = 3 per group).ESerum E level in AKG‐treated male mice 3 h after i.p. injection (n = 8 per group).F–IOxygen consumption (F‐G) and RER (H‐I) in male C57BL/6 mice (10 weeks old) i.p. injected with saline, 10 mg/kg AKG, 1 mg/kg SR59230A (ADRB3 inhibitor), or AKG + SR59230A (n = 8 per group). All injections were performed at 7:00 am of the second day. Data are summarized in bar graph (G and I) by light or dark cycle of the second day.J–NBody weight gain (J), cumulative food intake (K), body composition (L), fat weight (M), and serum NEFA (N) of sham or adrenalectomized male C57BL/6 mice. Male mice were adrenalectomized at 8 weeks of age. Two weeks after surgeries, male mice were switched to HFD and given free access to tap water or 2% AKG for 9 weeks (n = 8 per group).O, PRepresentative images (O) and quantification (P) of BAT thermogenesis after 6‐h cold exposure at 4°C in sham or adrenalectomized male mice treated with AKG for 9 weeks (n = 8 per group).QThe mRNA expression of thermogenic genes in the BAT of sham or adrenalectomized male mice treated with AKG for 9 weeks (n = 6 per group).R, SImmunoblots (R) and quantification (S) of p‐HSL and ATGL protein in the gWAT of sham or adrenalectomized male mice treated with AKG for 9 weeks (n = 4 per group).T, UImmunoblots (T) and quantification (U) of UCP1 protein in the BAT of sham or adrenalectomized male mice treated with AKG for 9 weeks (n = 4 per group).Data information: Results are presented as mean ± SEM. In (A), *P ≤ 0.05 by non‐paired Student's t‐test compared with before injection. In (C–E), *P ≤ 0.05 and **P ≤ 0.01 by non‐paired Student's t‐test. In (J, K), *P ≤ 0.05 by two‐way ANOVA followed by post hoc Bonferroni tests. In (G, I, L–N, P, Q, S and U), different letters between bars indicate P ≤ 0.05 by one‐way ANOVA followed by post hoc Tukey's tests.Source data are available online for this figure.CC BY · PubMed Central
Figure EV4 Acute in vivo effects of AKG A, BSerum levels of NE (A) and NEFA (B) in male C57BL/6 mice (10 weeks old) 3 h after i.p. injection of saline or AKG (10 mg/kg) (n = 5–6 per group).CThe mRNA expression of thermogenic genes in male C57BL/6 mice (10 weeks old) 3 h after i.p. injection of saline or AKG (10 mg/kg) (n = 5–6 per group).DImmunoblots and quantification of UCP1 in BAT of male C57BL/6 mice (10 weeks old) 3 h after i.p. injection of saline or AKG (10 mg/kg) (n = 3 per group).EImmunoblots and quantification of PLCβ and p‐Erk in the adrenal glands of male C57BL/6 mice (10 weeks old) 3 h after i.p. injection of saline or AKG (10 mg/kg) (n = 3 per group).F–IPhysical activity (pedometer; F, G) and heart rate (H, I) of male mice i.p. injected with 10 mg/kg AKG or saline at 7:00 am (n = 8 per group).J–LBlood pressure of male mice i.p. injected with 10 mg/kg AKG or saline (n = 8 per group).M–SSerum levels of succinate (SUC) (M), fumaric acid (FUMA) (N), pyruvic acid (Pyr) (O), oxaloacetic acid (OAA) (P), α‐ketoleucine (α‐kehex) (Q), alpha‐ketoisovaleric acid (α‐keval) (R), and 2‐hydroxy‐3‐methylbutyric acid (2H3MA) (S) in male C57BL/6 mice (10 weeks old) 3 h after i.p. injection of saline or AKG (10 mg/kg) (n = 8 per group).Data information: Results are presented as mean ± SEM. In (A–E, G, I, L, N and Q), *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.01 by non‐paired Student's t‐test. In (F, H, J and K), *P ≤ 0.05 by two‐way ANOVA followed by post hoc Bonferroni tests.
Figure EV4 Acute in vivo effects of AKG A, BSerum levels of NE (A) and NEFA (B) in male C57BL/6 mice (10 weeks old) 3 h after i.p. injection of saline or AKG (10 mg/kg) (n = 5–6 per group).CThe mRNA expression of thermogenic genes in male C57BL/6 mice (10 weeks old) 3 h after i.p. injection of saline or AKG (10 mg/kg) (n = 5–6 per group).DImmunoblots and quantification of UCP1 in BAT of male C57BL/6 mice (10 weeks old) 3 h after i.p. injection of saline or AKG (10 mg/kg) (n = 3 per group).EImmunoblots and quantification of PLCβ and p‐Erk in the adrenal glands of male C57BL/6 mice (10 weeks old) 3 h after i.p. injection of saline or AKG (10 mg/kg) (n = 3 per group).F–IPhysical activity (pedometer; F, G) and heart rate (H, I) of male mice i.p. injected with 10 mg/kg AKG or saline at 7:00 am (n = 8 per group).J–LBlood pressure of male mice i.p. injected with 10 mg/kg AKG or saline (n = 8 per group).M–SSerum levels of succinate (SUC) (M), fumaric acid (FUMA) (N), pyruvic acid (Pyr) (O), oxaloacetic acid (OAA) (P), α‐ketoleucine (α‐kehex) (Q), alpha‐ketoisovaleric acid (α‐keval) (R), and 2‐hydroxy‐3‐methylbutyric acid (2H3MA) (S) in male C57BL/6 mice (10 weeks old) 3 h after i.p. injection of saline or AKG (10 mg/kg) (n = 8 per group).Data information: Results are presented as mean ± SEM. In (A–E, G, I, L, N and Q), *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.01 by non‐paired Student's t‐test. In (F, H, J and K), *P ≤ 0.05 by two‐way ANOVA followed by post hoc Bonferroni tests.CC BY · PubMed Central
Figure EV5 Metabolic effects of AKG in in vitro and ex vivo models of BAT and adrenal gland A–HOxygen consumption rate (OCR) of primary brown adipocyte (A, B), adrenal chromaffin cell line (C, D), C2C12 cell line (E, F), and HepG2 cell line (G, H) treated with vehicle or 100 μM AKG for 3 h (n = 3 per group). OCR was monitored using the Agilent Seahorse XFp analyzer with the sequential injection of oligomycin, FCCP, and rotenone/antimycin.I, JImmunoblots (I) and quantification (J) of p‐AMPKα and p‐FoxO1 in primary brown adipocytes treated with vehicle or 100 μM AKG (n = 3 per group).KOxygen consumption rate (OCR) of ex vivo BAT cultured with vehicle, 50 μM AKG, 100 μM AKG, or 10 μM NE for 5, 15, 25, 25, 45, and 55 min (n = 3 per group).LMedium NEFA level from ex vivo BAT treated with vehicle, 50 μM AKG, 100 μM AKG, or 10 μM NE for 30 min (n = 6 per group).M, NMedium E (M) and NE (N) levels from ex vivo adrenal gland treated with vehicle or 100 μM AKG for 30 min in vitro (n = 5–6 per group).OImmunoblots and quantification of PLCβ in ex vivo adrenal gland treated with vehicle or 100 μM AKG for 30 min in vitro (n = 3 per group).PIntracellular calcium ion [Ca2+] changes in in vitro adrenal chromaffin cells treated with vehicle, 100 μM AKG, 100 μM succinate, or 100 μM glutamine (n = 30 per group).QIntracellular calcium ion [Ca2+] changes in in vitro adrenal chromaffin cells treated with vehicle or 5, 50, 60, 80, or 100 μM AKG (n = 30 per group).R, SMedium E (R) or NE (S) level from in vitro adrenal chromaffin cells treated with vehicle or 5, 50, 60, 80, or 100 μM AKG for 30 min (n = 8–18 per group).Data information: Results are presented as mean ± SEM. In (B, D, F, H, J, and M–O), *P ≤ 0.05 by non‐paired Student's t‐test. In (K and P–Q), *P ≤ 0.05 by two‐way ANOVA followed by post hoc Bonferroni tests. In (L and R–S), different letters indicate significant differences between groups by one‐way ANOVA followed by post hoc Tukey's tests.Source data are available online for this figure.
Figure EV5 Metabolic effects of AKG in in vitro and ex vivo models of BAT and adrenal gland A–HOxygen consumption rate (OCR) of primary brown adipocyte (A, B), adrenal chromaffin cell line (C, D), C2C12 cell line (E, F), and HepG2 cell line (G, H) treated with vehicle or 100 μM AKG for 3 h (n = 3 per group). OCR was monitored using the Agilent Seahorse XFp analyzer with the sequential injection of oligomycin, FCCP, and rotenone/antimycin.I, JImmunoblots (I) and quantification (J) of p‐AMPKα and p‐FoxO1 in primary brown adipocytes treated with vehicle or 100 μM AKG (n = 3 per group).KOxygen consumption rate (OCR) of ex vivo BAT cultured with vehicle, 50 μM AKG, 100 μM AKG, or 10 μM NE for 5, 15, 25, 25, 45, and 55 min (n = 3 per group).LMedium NEFA level from ex vivo BAT treated with vehicle, 50 μM AKG, 100 μM AKG, or 10 μM NE for 30 min (n = 6 per group).M, NMedium E (M) and NE (N) levels from ex vivo adrenal gland treated with vehicle or 100 μM AKG for 30 min in vitro (n = 5–6 per group).OImmunoblots and quantification of PLCβ in ex vivo adrenal gland treated with vehicle or 100 μM AKG for 30 min in vitro (n = 3 per group).PIntracellular calcium ion [Ca2+] changes in in vitro adrenal chromaffin cells treated with vehicle, 100 μM AKG, 100 μM succinate, or 100 μM glutamine (n = 30 per group).QIntracellular calcium ion [Ca2+] changes in in vitro adrenal chromaffin cells treated with vehicle or 5, 50, 60, 80, or 100 μM AKG (n = 30 per group).R, SMedium E (R) or NE (S) level from in vitro adrenal chromaffin cells treated with vehicle or 5, 50, 60, 80, or 100 μM AKG for 30 min (n = 8–18 per group).Data information: Results are presented as mean ± SEM. In (B, D, F, H, J, and M–O), *P ≤ 0.05 by non‐paired Student's t‐test. In (K and P–Q), *P ≤ 0.05 by two‐way ANOVA followed by post hoc Bonferroni tests. In (L and R–S), different letters indicate significant differences between groups by one‐way ANOVA followed by post hoc Tukey's tests.Source data are available online for this figure.CC BY · PubMed Central
Figure 5 OXGR1 is required for the stimulatory effects of AKG on thermogenesis and lipolysis AThe mRNA expression of AKG‐sensing genes in the adrenal gland tissue of 12‐week‐old male C57BL/6 mice (n = 4 per group).BThe mRNA expression of OXGR1 in different tissues of 12‐week‐old male C57BL/6 mice (n = 3 per group).COXGR1 localization in adrenal gland medulla indicated by fluorescent staining of OXGR1 (green).DThe mRNA expression of OXGR1 in the adrenal gland of male mice 3 h after i.p. injection of saline or 10 mg/kg AKG, or immediately after 40‐min resistance exercise (n = 8 per group).EImmunoblots and quantification of OXGR1 protein expression in adrenal chromaffin cells treated with negative control (NC) siRNA or siOXGR1 (n = 3 per group).FE level in the medium from adrenal chromaffin cells cultured with vehicle + NC, vehicle + siOXGR1, AKG (100 μM) + NC or AKG + siOXGR1 for 30 min (n = 8 per group).GIntracellular calcium ion [Ca2+] changes in adrenal medulla cells cultured with vehicle + NC, vehicle + siOXGR1, AKG (100 μM) + NC, or AKG + siOXGR1 (n = 30 per group).H, IBody weight gain (H) and cumulative food intake (I) of male WT control (littermates) or OXGR1 global knockout (OXGR1KO) mice. At 12 weeks of age, both control and KO mice were switched to HFD and further divided into two groups receiving tap water or water supplemented with 2% AKG for 13 weeks (n = 8 per group).J, KRepresentative images of body composition (J) and fat and lean mass index (K) of male WT or OXGR1KO mice treated with AKG for 13 weeks (n = 8 per group).L, MWeight index of iWAT (L) and gWAT (M) in male WT or OXGR1KO mice treated with AKG for 13 weeks (n = 8 per group).N, OImmunoblots (N) and quantification (O) of p‐HSL and ATGL protein in gWAT of male WT or OXGR1KO mice treated with AKG for 13 weeks (n = 4 per group).P–SOxygen consumption (P‐Q) and RER (R‐S) of male WT or OXGR1KO mice treated with AKG for 13 weeks (n = 8 per group).Data information: Results are presented as mean ± SEM. In (A, B, F, K–M, O, Q, and S), different letters between bars indicate P ≤ 0.05 by one‐way ANOVA followed by post hoc Tukey's tests. In (D), **P ≤ 0.01 by one‐way ANOVA followed by post hoc Dunnett's tests. In (E), **P ≤ 0.01 by non‐paired Student's t‐test. In (G–I), *P ≤ 0.05 by two‐way ANOVA followed by post hoc Bonferroni tests.Source data are available online for this figure.
Figure 5 OXGR1 is required for the stimulatory effects of AKG on thermogenesis and lipolysis AThe mRNA expression of AKG‐sensing genes in the adrenal gland tissue of 12‐week‐old male C57BL/6 mice (n = 4 per group).BThe mRNA expression of OXGR1 in different tissues of 12‐week‐old male C57BL/6 mice (n = 3 per group).COXGR1 localization in adrenal gland medulla indicated by fluorescent staining of OXGR1 (green).DThe mRNA expression of OXGR1 in the adrenal gland of male mice 3 h after i.p. injection of saline or 10 mg/kg AKG, or immediately after 40‐min resistance exercise (n = 8 per group).EImmunoblots and quantification of OXGR1 protein expression in adrenal chromaffin cells treated with negative control (NC) siRNA or siOXGR1 (n = 3 per group).FE level in the medium from adrenal chromaffin cells cultured with vehicle + NC, vehicle + siOXGR1, AKG (100 μM) + NC or AKG + siOXGR1 for 30 min (n = 8 per group).GIntracellular calcium ion [Ca2+] changes in adrenal medulla cells cultured with vehicle + NC, vehicle + siOXGR1, AKG (100 μM) + NC, or AKG + siOXGR1 (n = 30 per group).H, IBody weight gain (H) and cumulative food intake (I) of male WT control (littermates) or OXGR1 global knockout (OXGR1KO) mice. At 12 weeks of age, both control and KO mice were switched to HFD and further divided into two groups receiving tap water or water supplemented with 2% AKG for 13 weeks (n = 8 per group).J, KRepresentative images of body composition (J) and fat and lean mass index (K) of male WT or OXGR1KO mice treated with AKG for 13 weeks (n = 8 per group).L, MWeight index of iWAT (L) and gWAT (M) in male WT or OXGR1KO mice treated with AKG for 13 weeks (n = 8 per group).N, OImmunoblots (N) and quantification (O) of p‐HSL and ATGL protein in gWAT of male WT or OXGR1KO mice treated with AKG for 13 weeks (n = 4 per group).P–SOxygen consumption (P‐Q) and RER (R‐S) of male WT or OXGR1KO mice treated with AKG for 13 weeks (n = 8 per group).Data information: Results are presented as mean ± SEM. In (A, B, F, K–M, O, Q, and S), different letters between bars indicate P ≤ 0.05 by one‐way ANOVA followed by post hoc Tukey's tests. In (D), **P ≤ 0.01 by one‐way ANOVA followed by post hoc Dunnett's tests. In (E), **P ≤ 0.01 by non‐paired Student's t‐test. In (G–I), *P ≤ 0.05 by two‐way ANOVA followed by post hoc Bonferroni tests.Source data are available online for this figure.CC BY · PubMed Central
Figure 6 OXGR1 expressed by adrenal gland mediates the stimulatory effects of AKG on thermogenesis and lipolysis A, BBody weight gain (A) and cumulative food intake (B) of male OXGR1 adrenal‐specific reexpression mice (OXGR1REAG). Male OXGR1KO mice (8 weeks old) were adrenal‐specifically injected with control HBAAV2/9‐GFP (OXGR1KO control) or HBAAV2/9‐OXGR1 (OXGR1REAG). Two weeks after injections, mice were switched to HFD and further divided into two groups receiving tap water or water supplemented with 2% AKG for 12 weeks (n = 8 per group).C, DRepresentative image of body composition (C) and fat and lean mass index (D) of male OXGR1REAG mice treated with AKG for 12 weeks (n = 8 per group).E, FWeight index of gWAT (E) and iWAT (F) in male OXGR1REAG mice treated with AKG for 12 weeks (n = 8 per group).G, HImmunoblots (G) and quantification (H) of p‐HSL and ATGL protein in gWAT of male OXGR1REAG mice treated with AKG for 12 weeks (n = 8 per group).I–LOxygen consumption (I–J) and RER (K–L) of male OXGR1REAG mice treated with AKG for 12 weeks (n = 8 per group).Data information: Results are presented as mean ± SEM. In (A, B), *P ≤ 0.05 by two‐way ANOVA followed by post hoc Bonferroni tests. In (D–F, H, J and L), different letters between bars indicate P ≤ 0.05 by one‐way ANOVA followed by post hoc Tukey's tests.
Figure 6 OXGR1 expressed by adrenal gland mediates the stimulatory effects of AKG on thermogenesis and lipolysis A, BBody weight gain (A) and cumulative food intake (B) of male OXGR1 adrenal‐specific reexpression mice (OXGR1REAG). Male OXGR1KO mice (8 weeks old) were adrenal‐specifically injected with control HBAAV2/9‐GFP (OXGR1KO control) or HBAAV2/9‐OXGR1 (OXGR1REAG). Two weeks after injections, mice were switched to HFD and further divided into two groups receiving tap water or water supplemented with 2% AKG for 12 weeks (n = 8 per group).C, DRepresentative image of body composition (C) and fat and lean mass index (D) of male OXGR1REAG mice treated with AKG for 12 weeks (n = 8 per group).E, FWeight index of gWAT (E) and iWAT (F) in male OXGR1REAG mice treated with AKG for 12 weeks (n = 8 per group).G, HImmunoblots (G) and quantification (H) of p‐HSL and ATGL protein in gWAT of male OXGR1REAG mice treated with AKG for 12 weeks (n = 8 per group).I–LOxygen consumption (I–J) and RER (K–L) of male OXGR1REAG mice treated with AKG for 12 weeks (n = 8 per group).Data information: Results are presented as mean ± SEM. In (A, B), *P ≤ 0.05 by two‐way ANOVA followed by post hoc Bonferroni tests. In (D–F, H, J and L), different letters between bars indicate P ≤ 0.05 by one‐way ANOVA followed by post hoc Tukey's tests.CC BY · PubMed Central
Figure 7 OXGR1 is required for metabolic beneficial effects of resistance exercise ABody weight gain in male WT littermates and OXGR1KO mice. At 8 weeks of age, male C57BL/6 WT control or OXGR1KO mice were switched to HFD. After 12 weeks of HFD feeding, mice were further divided into two groups receiving non‐exercise or resistance exercise for 14 days (n = 8 per group).BExercise‐induced body weight loss in male WT littermates and OXGR1KO mice. Body weights from exercise mice were subtracted by the average body weight of the non‐exercise control group for each genotype (n = 8 per group).CExercise‐induced fat mass loss in male WT littermates and OXGR1KO mice. Fat mass from exercise mice was subtracted by the average fat mass of the non‐exercise control group for each genotype (n = 8 per group).DCumulative food intake of male WT littermates and OXGR1KO mice after 14‐day resistance exercise (n = 8 per group).E, FWeight index of gWAT (E) and iWAT (F) of male OXGR1KO mice after 14‐day resistance exercise (n = 8 per group).GBody composition of male OXGR1KO mice after 14‐day resistance exercise (n = 8 per group).HSerum AKG levels of male WT and OXGR1KO mice after resistance exercise. Male WT and OXGR1KO mice (10 weeks old) fed with normal chow were receiving resistance exercise for 40 min (n = 8 per group). The serum AKG levels were tested before and immediately after exercise.ISerum E level in male OXGR1KO mice after 14‐day resistance exercise (n = 8 per group).J–LThe mRNA expression (J) and protein expression of UCP1 (K) in the BAT or the mRNA expression of HSL and ATGL (L) in the gWAT of male OXGR1KO mice after 14‐day resistance exercise (n = 4 per group).M–POxygen consumption (M, N) and RER (O, P) in male OXGR1KO mice after 14‐day resistance exercise (n = 8 per group).Data information: Results are presented as mean ± SEM. In (A–D) *P ≤ 0.05 and **P ≤ 0.01 by two‐way ANOVA followed by post hoc Bonferroni tests. In (E–L, N and P), different letters between bars indicate P ≤ 0.05 by one‐way ANOVA followed by post hoc Tukey's tests.
Figure 7 OXGR1 is required for metabolic beneficial effects of resistance exercise ABody weight gain in male WT littermates and OXGR1KO mice. At 8 weeks of age, male C57BL/6 WT control or OXGR1KO mice were switched to HFD. After 12 weeks of HFD feeding, mice were further divided into two groups receiving non‐exercise or resistance exercise for 14 days (n = 8 per group).BExercise‐induced body weight loss in male WT littermates and OXGR1KO mice. Body weights from exercise mice were subtracted by the average body weight of the non‐exercise control group for each genotype (n = 8 per group).CExercise‐induced fat mass loss in male WT littermates and OXGR1KO mice. Fat mass from exercise mice was subtracted by the average fat mass of the non‐exercise control group for each genotype (n = 8 per group).DCumulative food intake of male WT littermates and OXGR1KO mice after 14‐day resistance exercise (n = 8 per group).E, FWeight index of gWAT (E) and iWAT (F) of male OXGR1KO mice after 14‐day resistance exercise (n = 8 per group).GBody composition of male OXGR1KO mice after 14‐day resistance exercise (n = 8 per group).HSerum AKG levels of male WT and OXGR1KO mice after resistance exercise. Male WT and OXGR1KO mice (10 weeks old) fed with normal chow were receiving resistance exercise for 40 min (n = 8 per group). The serum AKG levels were tested before and immediately after exercise.ISerum E level in male OXGR1KO mice after 14‐day resistance exercise (n = 8 per group).J–LThe mRNA expression (J) and protein expression of UCP1 (K) in the BAT or the mRNA expression of HSL and ATGL (L) in the gWAT of male OXGR1KO mice after 14‐day resistance exercise (n = 4 per group).M–POxygen consumption (M, N) and RER (O, P) in male OXGR1KO mice after 14‐day resistance exercise (n = 8 per group).Data information: Results are presented as mean ± SEM. In (A–D) *P ≤ 0.05 and **P ≤ 0.01 by two‐way ANOVA followed by post hoc Bonferroni tests. In (E–L, N and P), different letters between bars indicate P ≤ 0.05 by one‐way ANOVA followed by post hoc Tukey's tests.CC BY · PubMed Central
Figure 8 p65/NF‐κB inflammatory pathway is required for the stimulatory effects of AKG on E release of adrenal chromaffin cells in vitro AIngenuity pathway analysis (IPA) of AKG‐induced transcriptome signature in adrenal chromaffin cells treated with AKG. The mRNA was extracted from adrenal chromaffin cells after 3‐h incubation of vehicle or AKG (100 μM) (n = 3 per group).B, CImmunoblots (B) and quantification (C) of p‐IKK/IKK, p65, p‐IκB/IκB, and OXGR1 protein in adrenal chromaffin cells cultured with vehicle + NC, vehicle + siOXGR1, AKG (100 μM) + NC, or AKG + siOXGR1 for 3 h (n = 3 per group).Dp65 translocation in adrenal chromaffin cells cultured with vehicle + NC, vehicle + siOXGR1, AKG (100 μM) + NC, or AKG + siOXGR1 for 3 h (n = 3 per group). Scale bars, 100 μm.E, FImmunoblots (E) and quantification (F) of p‐IKK/IKK, p65, and p‐IκB/IκB protein in adrenal chromaffin cells cultured with vehicle, AKG (100 μM), IKK inhibitor IKK16, or AKG + IKK16 for 3 h.GE level in the medium from adrenal chromaffin cells cultured with vehicle, AKG (100 μM), IKK16, or AKG + IKK16 for 3 h (n = 10 per group).Data information: Results are presented as mean ± SEM. In (C, F and G), different letters between bars indicate P ≤ 0.05 by one‐way ANOVA followed by post hoc Tukey's tests.
Figure 8 p65/NF‐κB inflammatory pathway is required for the stimulatory effects of AKG on E release of adrenal chromaffin cells in vitro AIngenuity pathway analysis (IPA) of AKG‐induced transcriptome signature in adrenal chromaffin cells treated with AKG. The mRNA was extracted from adrenal chromaffin cells after 3‐h incubation of vehicle or AKG (100 μM) (n = 3 per group).B, CImmunoblots (B) and quantification (C) of p‐IKK/IKK, p65, p‐IκB/IκB, and OXGR1 protein in adrenal chromaffin cells cultured with vehicle + NC, vehicle + siOXGR1, AKG (100 μM) + NC, or AKG + siOXGR1 for 3 h (n = 3 per group).Dp65 translocation in adrenal chromaffin cells cultured with vehicle + NC, vehicle + siOXGR1, AKG (100 μM) + NC, or AKG + siOXGR1 for 3 h (n = 3 per group). Scale bars, 100 μm.E, FImmunoblots (E) and quantification (F) of p‐IKK/IKK, p65, and p‐IκB/IκB protein in adrenal chromaffin cells cultured with vehicle, AKG (100 μM), IKK inhibitor IKK16, or AKG + IKK16 for 3 h.GE level in the medium from adrenal chromaffin cells cultured with vehicle, AKG (100 μM), IKK16, or AKG + IKK16 for 3 h (n = 10 per group).Data information: Results are presented as mean ± SEM. In (C, F and G), different letters between bars indicate P ≤ 0.05 by one‐way ANOVA followed by post hoc Tukey's tests.CC BY · PubMed Central

Verification

Claims the paper makes

12 Valid · 1 Not valid · 8 Not checked · 181 Own results and interpretations

118 more claims

Create a free account to see all 202 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 26
  • It may state two separate claims as one. 62
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Show all 114 references

Cited by

See all 92

Metadata

Authors
Yuan, Y., Xu, P., Jiang, Q., Cai, X., Wang, T., Peng, W., Sun, J., Zhu, C., Zhang, C., Yue, D., He, Z., Yang, J., Zeng, Y., Du, M., Zhang, F., Ibrahimi, L., Schaul, S., Jiang, Y., Wang, J., Sun, J., Wang, Q., Liu, L., Wang, S., Wang, L., Zhu, X., Gao, P., Xi, Q., Yin, C., Li, F., Xu, G., Zhang, Y., & Shu, G.
Affiliations
  • South China Agricultural University (CN)
  • University of Illinois Chicago (US)
  • Shanghai Jiao Tong University (CN)
Corresponding author
Shu, Gang
Venue
The EMBO Journal
Published
2020-02-27
Volume
39
Issue
7
Pages
e103304-e103304
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W3007444694
Cited by
88
References
114
Citations by year
2026: 16 · 2025: 19 · 2024: 17 · 2023: 16 · 2022: 12 · 2021: 6 · 2020: 2
FWCI
5.42
Type
journal article
Language
en
Open access
Licence
Locations
  • The EMBO Journal (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (submittedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Key Point Research and Invention Program (2018YFD0500403, 2016YFD0501205)
  • Research and Development Projects in Key Areas of Guangdong Province (2019B020218001)
  • Innovation Team Project in Universities of Guangdong Province (2017KCXTD002)
  • National Institute of Diabetes and Digestive and Kidney Diseases from National Institutes of Health (R00DK107008, K01DK111771)
  • National Natural Science Foundation of China (31790411, 31572480)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Physiology (medical) › Exercise and Physiological Responses
Keywords
alpha-ketoglutarate, resistance training, muscle hypertrophy, fat loss, adrenal gland, adrenaline secretion, brown adipose tissue thermogenesis, white adipose tissue lipolysis, TCA cycle
MeSH terms
Adult, Aged, Animals, Cell Line, Female, Humans, Ketoglutaric Acids, Male, Middle Aged, Muscular Atrophy, Receptors, Purinergic P2, Models, Animal, Mice, Resistance Training, Gene Knockout Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exercise‐induced α‐ketoglutaric acid stimulates muscle hypertrophy and fat loss through OXGR1‐dependent adrenal activation. https://app.cochat.ai/papers/10.15252/embj.2019103304
The paper
Yuan, Y., Xu, P., Jiang, Q., Cai, X., Wang, T., Peng, W., Sun, J., Zhu, C., Zhang, C., Yue, D., He, Z., Yang, J., Zeng, Y., Du, M., Zhang, F., Ibrahimi, L., Schaul, S., Jiang, Y., Wang, J., . . . Shu, G. (2020). Exercise‐induced α‐ketoglutaric acid stimulates muscle hypertrophy and fat loss through OXGR1‐dependent adrenal activation. The EMBO Journal. https://doi.org/10.15252/embj.2019103304

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.